4.1 Article

A novel interstitial deletion of 10q24.2q24.32 in a patient with renal coloboma syndrome

Journal

EUROPEAN JOURNAL OF MEDICAL GENETICS
Volume 55, Issue 3, Pages 211-215

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejmg.2012.01.011

Keywords

PAX2; RCS; Haploinsufficiency; Coloboma; Renal hypoplasia

Ask authors/readers for more resources

Renal coloboma syndrome (RCS) is considered to be a rare autosomal dominant inherited disorder characterized by renal malformations and optic disc coloboma. Ocular anomalies range from asymptomatic abnormalities in retinal blood vessel patterning to large excavations of the optic nerve associated with reduced visual acuity. Commonly observed manifestations of the kidney are renal hypoplasia and vesicoureteric reflux leading to end-stage renal disease. Mutations in the PAX2 gene on chromosome 10 have been identified in patients with RCS. Up to date, nucleotide substitutions, insertions, small deletions, one de novo translocation, and one 240 kb deletion of the coding region of the PAX2 gene have been described to be responsible for RCS. We report here a new case of a patient with RCS due to a deletion of 3.8 Mb on chromosome 10q. Deletions on the long arm of chromosome 10 harboring the PAX2 gene seem to be a rare cause for RCS. Nevertheless, array-CGH testing should represent an important and valuable addition to PAX2 gene sequencing in diagnostic of RCS. (C) 2012 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome

Joost Kummeling, Diante E. Stremmelaar, Nicholas Raun, Margot R. F. Reijnders, Marjolein H. Willemsen, Martina Ruiterkamp-Versteeg, Marga Schepens, Calvin C. O. Man, Christian Gilissen, Megan T. Cho, Kirsty McWalter, Margje Sinnema, James W. Wheless, Marleen E. H. Simon, Casie A. Genetti, Alicia M. Casey, Paulien A. Terhal, Jasper J. van Der Smagt, Koen L. van Gassen, Pascal Joset, Angela Bahr, Katharina Steindl, Anita Rauch, Elmar Keller, Annick Raas-Rothschild, David A. Koolen, Pankaj B. Agrawal, Trevor L. Hoffman, Nina N. Powell-Hamilton, Isabelle Thiffault, Kendra Engleman, Dihong Zhou, Olaf Bodamer, Julia Hoefele, Korbinian M. Riedhammer, Eva M. C. Schwaibold, Velibor Tasic, Dirk Schubert, Deniz Top, Rolph Pfundt, Martin R. Higgs, Jamie M. Kramer, Tjitske Kleefstra

Summary: Mutations in histone methyltransferases (HMTs), such as SETD1A, are major contributing factors in neurodevelopmental disorders (NDDs). Identifying clinical features of the Mendelian syndrome associated with haploinsufficiency of SETD1A, this study found that individuals with SETD1A variants present with global developmental delay, intellectual disability, facial dysmorphisms, behavioral and psychiatric problems. Patient-derived cell lines with SETD1A variants showed DNA damage repair defects, suggesting these variants act as loss-of-function alleles. The study also revealed the importance of SETD1A in postmitotic neurons for normal memory function in Drosophila melanogaster, indicating a role in post development neuronal processes and cognitive functioning.

MOLECULAR PSYCHIATRY (2021)

Article Genetics & Heredity

Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial

Jan Boeckhaus, Julia Hoefele, Korbinian M. Riedhammer, Burkhard Tonshoff, Rasmus Ehren, Lars Pape, Kay Latta, Henry Fehrenbach, Baerbel Lange-Sperandio, Matthias Kettwig, Peter Hoyer, Hagen Staude, Martin Konrad, Ulrike John, Jutta Gellermann, Bernd Hoppe, Matthias Galiano, Michaela Gessner, Michael Pohl, Carsten Bergmann, Tim Friede, Oliver Gross

Summary: Early initiation of therapy in patients with Alport syndrome can slow down renal failure by many years. Genotype-phenotype correlations suggest that the location and character of the individual's variant correlate with the renal outcome and any extra renal manifestations. In-depth clinical and genetic data analysis of children in the EARLY PRO-TECT Alport trial revealed important insights into disease progression and the impact of genetic variants on clinical outcomes.

CLINICAL GENETICS (2021)

Article Biochemistry & Molecular Biology

Identification of disease-causing variants by comprehensive genetic testing with exome sequencing in adults with suspicion of hereditary FSGS

Matthias Christoph Braunisch, Korbinian Maria Riedhammer, Pierre-Maurice Herr, Sarah Draut, Roman Guenthner, Matias Wagner, Marc Weidenbusch, Adrian Lungu, Bader Alhaddad, Lutz Renders, Tim M. Strom, Uwe Heemann, Thomas Meitinger, Christoph Schmaderer, Julia Hoefele

Summary: In 29% of adult patients suspected of hereditary FSGS, a monogenic cause could be identified. The long delay to a definite genetic diagnosis emphasizes the importance of early genetic diagnosis for personalized treatment options, including weaning off immunosuppressive treatment, avoiding repeated renal biopsy, and providing accurate genetic counseling.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Article Genetics & Heredity

De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis

Patricia L. Weng, Amar J. Majmundar, Kamal Khan, Tze Y. Lim, Shirlee Shril, Gina Jin, John Musgrove, Minxian Wang, Dina F. Ahram, Vimla S. Aggarwal, Louise E. Bier, Erin L. Heinzen, Ana C. Onuchic-Whitford, Nina Mann, Florian Buerger, Ronen Schneider, Konstantin Deutsch, Thomas M. Kitzler, Verena Klambt, Amy Kolb, Youying Mao, Christelle Moufawad El Achkar, Adele Mitrotti, Jeremiah Martino, Bodo B. Beck, Janine Altmuller, Marcus R. Benz, Shoji Yano, Mohamad A. Mikati, Talha Gunduz, Heidi Cope, Vandana Shashi, Howard Trachtman, Monica Bodria, Gianluca Caridi, Isabella Pisani, Enrico Fiaccadori, Asmaa S. AbuMaziad, Julian A. Martinez-Agosto, Ora Yadin, Jonathan Zuckerman, Arang Kim, Ulrike John-Kroegel, Amanda Tyndall, Jillian S. Parboosingh, A. Micheil Innes, Agnieszka Bierzynska, Ania B. Koziell, Mordi Muorah, Moin A. Saleem, Julia Hoefele, Korbinian M. Riedhammer, Ali G. Gharavi, Vaidehi Jobanputra, Emma Pierce-Hoffman, Eleanor G. Seaby, Anne O'Donnell-Luria, Heidi L. Rehm, Shrikant Mane, Vivette D. D'Agati, Martin R. Pollak, Gian Marco Ghiggeri, Richard P. Lifton, David B. Goldstein, Erica E. Davis, Friedhelm Hildebrandt, Simone Sanna-Cherchi

Summary: Focal segmental glomerulosclerosis (FSGS) is a major pathology for steroid-resistant nephrotic syndrome (SRNS) and chronic kidney disease, caused by recessive mutations or de novo variants (DNVs). Truncating variants in the TRIM8 gene are associated with FSGS, indicating a link between neuro-renal syndromes and emphasizing the connection between the nervous system and kidneys.

AMERICAN JOURNAL OF HUMAN GENETICS (2021)

Article Genetics & Heredity

De novo variants in neurodevelopmental disorders-experiences from a tertiary care center

Theresa Brunet, Robert Jech, Melanie Brugger, Reka Kovacs, Bader Alhaddad, Gloria Leszinski, Korbinian M. Riedhammer, Dominik S. Westphal, Isabella Mahle, Katharina Mayerhanser, Matej Skorvanek, Sandrina Weber, Elisabeth Graf, Riccardo Berutti, Jan Necpal, Petra Havrankova, Petra Pavelekova, Maja Hempel, Urania Kotzaeridou, Georg F. Hoffmann, Steffen Leiz, Christine Makowski, Timo Roser, Sebastian A. Schroeder, Robert Steinfeld, Gertrud Strobl-Wildemann, Julia Hoefele, Ingo Borggraefe, Felix Distelmaier, Tim M. Strom, Juliane Winkelmann, Thomas Meitinger, Michael Zech, Matias Wagner

Summary: Up to 40% of neurodevelopmental disorders have a documented underlying monogenic defect, primarily due to de novo variants. The study showed an overall diagnostic yield of 49.8%, with de novo variants contributing to more than 80% of all solved cases. Additionally, novel disease genes and potential pathogenic variants were identified in this research.

CLINICAL GENETICS (2021)

Editorial Material Biochemistry & Molecular Biology

Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria

Judy Savige, Helen Storey, Elizabeth Watson, Jens Michael Hertz, Constantinos Deltas, Alessandra Renieri, Francesca Mari, Pascale Hilbert, Pavlina Plevova, Peter Byers, Agne Cerkauskaite, Martin Gregory, Rimante Cerkauskiene, Danica Galesic Ljubanovic, Francesca Becherucci, Carmela Errichiello, Laura Massella, Valeria Aiello, Rachel Lennon, Louise Hopkinson, Ania Koziell, Adrian Lungu, Hansjorg Martin Rothe, Julia Hoefele, Miriam Zacchia, Tamara Nikuseva Martic, Asheeta Gupta, Albertien van Eerde, Susie Gear, Samuela Landini, Viviana Palazzo, Laith Al-Rabadi, Kathleen Claes, Anniek Corveleyn, Evelien Van Hoof, Micheel van Geel, Maggie Williams, Emma Ashton, Hendica Belge, Elisabeth Ars, Agnieszka Bierzynska, Concetta Gangemi, Beata S. Lipska-Zietkiewicz

Summary: The meeting expanded the indications for screening for pathogenic variants in the COL4A5, COL4A3 and COL4A4 genes, refined the ACMG criteria for variant assessment, and identified mutational hotspots in the collagen IV alpha 5, alpha 3 and alpha 4 chains.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)

Article Allergy

Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency

Stefano Vavassori, Janet Chou, Laura Eva Faletti, Veronika Haunerdinger, Lennart Opitz, Pascal Joset, Christopher J. Fraser, Seraina Prader, Xianfei Gao, Luise A. Schuch, Matias Wagner, Julia Hoefele, Maria Elena Maccari, Ying Zhu, George Elakis, Michael T. Gabbett, Maria Forstner, Heymut Omran, Thomas Kaiser, Christina Kessler, Heike Olbrich, Patrick Frosk, Abduarahman Almutairi, Craig D. Platt, Megan Elkins, Sabrina Weeks, Tamar Rubin, Raquel Planas, Tommaso Marchetti, Danil Koovely, Verena Klambt, Neveen A. Soliman, Sandra von Hardenberg, Christian Klemann, Ulrich Baumann, Dominic Lenz, Andreas Klein-Franke, Martin Schwemmle, Michael Huber, Ekkehard Sturm, Steffen Hartleif, Karsten Haffner, Charlotte Gimpel, Barbara Brotschi, Guido Laube, Tayfun Gungor, Michael F. Buckley, Raimund Kottke, Christian Staufner, Friedhelm Hildebrandt, Simone Reu-Hofer, Solange Moll, Achim Weber, Hundeep Kaur, Stephan Ehl, Sebastian Hiller, Raif Geha, Tony Roscioli, Matthias Griese, Jana Pachlopnik Schmid

Summary: This study identified deleterious ZNFX1 variants in 15 patients with severe infections by both RNA and DNA viruses and virally triggered inflammatory episodes. ZNFX1 deficiency led to deregulated expression of interferon-stimulated genes and poorer clearance of viral infections, highlighting its crucial role in the immune response to viral infections.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Genetics & Heredity

Biallelic and monoallelic variants in PLXNA1 are implicated in a novel neurodevelopmental disorder with variable cerebral and eye anomalies

Gabriel C. Dworschak, Jaya Punetha, Jeshurun C. Kalanithy, Enrico Mingardo, Haktan B. Erdem, Zeynep C. Akdemir, Ender Karaca, Tadahiro Mitani, Dana Marafi, Jawid M. Fatih, Shalini N. Jhangiani, Jill V. Hunter, Tikam Chand Dakal, Bhanupriya Dhabhai, Omar Dabbagh, Hessa S. Alsaif, Fowzan S. Alkuraya, Reza Maroofian, Henry Houlden, Stephanie Efthymiou, Natalia Dominik, Vincenzo Salpietro, Tipu Sultan, Shahzad Haider, Farah Bibi, Holger Thiele, Julia Hoefele, Korbinian M. Riedhammer, Matias Wagner, Ilaria Guella, Michelle Demos, Boris Keren, Julien Buratti, Perrine Charles, Caroline Nava, Delphine Heron, Solveig Heide, Elise Valkanas, Leigh B. Waddell, Kristi J. Jones, Emily C. Oates, Sandra T. Cooper, Daniel MacArthur, Steffen Syrbe, Andreas Ziegler, Konrad Platzer, Volkan Okur, Wendy K. Chung, Sarah A. O'Shea, Roy Alcalay, Stanley Fahn, Paul R. Mark, Renzo Guerrini, Annalisa Vetro, Beth Hudson, Rhonda E. Schnur, George E. Hoganson, Jennifer E. Burton, Meriel McEntagart, Tobias Lindenberg, Oeznur Yilmaz, Benjamin Odermatt, Davut Pehlivan, Jennifer E. Posey, James R. Lupski, Heiko Reutter

Summary: The study found that different PLXNA1 variants can cause a neurodevelopmental syndrome, with main symptoms including developmental delay, brain, and eye anomalies. Biallelic variants may impact receptor molecule function, while monoallelic variants may interfere with downstream signaling through a dominant-negative effect.

GENETICS IN MEDICINE (2021)

Letter Pediatrics

Mosaic trisomy 12 diagnosed in a female patient: clinical features, genetic analysis, and review of the literature

Daniela Hainz, Marcus Krueger, Daniela Reber, Karl Mehnert, Theresa Brunet, Gabriele Lederer, Sabine Langer-Freitag, Julia Hoefele

WORLD JOURNAL OF PEDIATRICS (2021)

Article Genetics & Heredity

Renal and Skeletal Anomalies in a Cohort of Individuals With Clinically Presumed Hereditary Nephropathy Analyzed by Molecular Genetic Testing

Michaela Stippel, Korbinian M. Riedhammer, Barbel Lange-Sperandio, Michaela Gessner, Matthias C. Braunisch, Roman Gunthner, Martin Bald, Miriam Schmidts, Peter Strotmann, Velibor Tasic, Christoph Schmaderer, Lutz Renders, Uwe Heemann, Julia Hoefele

Summary: This study investigated the presence of skeletal anomalies as an extrarenal manifestation in individuals with hereditary podocytopathies, ciliopathies or CAKUT, finding that 12% of the cohort presented with both kidney disease and additional skeletal phenotypes. Pathogenic variants in known disease-associated genes were identified in 63% of these cases, highlighting the genetic heterogeneity and clinical variability of hereditary nephropathies.

FRONTIERS IN GENETICS (2021)

Article Transplantation

Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study

Jan Boeckhaus, Julia Hoefele, Korbinian M. Riedhammer, Mato Nagel, Bodo B. Beck, Mira Choi, Maik Gollasch, Carsten Bergmann, Joseph E. Sonntag, Victoria Troesch, Johanna Stock, Oliver Gross

Summary: Early therapy in Alport syndrome individuals with missense variants may delay renal failure, improve life expectancy, and enhance quality of life.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Editorial Material Biochemistry & Molecular Biology

The 2019 and 2021 International Workshops on Alport Syndrome

Sergio Daga, Jie Ding, Constantinos Deltas, Judy Savige, Beata S. Lipska-Zietkiewicz, Julia Hoefele, Frances Flinter, Daniel P. Gale, Marina Aksenova, Hirofumi Kai, Laura Perin, Moumita Barua, Roser Torra, Jeff H. Miner, Laura Massella, Danica Galesic Ljubanovic, Rachel Lennon, Andre B. Weinstock, Bertrand Knebelmann, Agne Cerkauskaite, Susie Gear, Oliver Gross, A. Neil Turner, Margherita Baldassarri, Anna Maria Pinto, Alessandra Renieri

Summary: Alport syndrome is an inherited kidney disease that affects males more severely than females and is sometimes associated with hearing loss. Three genes responsible for the disease were discovered in the late twentieth century. The international workshops in 2019 and 2021 discussed various topics related to the syndrome, including disease renaming, increasing the diagnostic rate, genotype-phenotype correlation, new therapeutics, and gene therapy.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Correction Biochemistry & Molecular Biology

The 2019 and 2021 International workshops on Alport syndrome (vol 30, 507, 2022)

Sergio Daga, Jie Ding, Constantinos Deltas, Judy Savige, Beata S. Lipska-Zietkiewicz, Julia Hoefele, Frances Flinter, Daniel P. Gale, Marina Aksenova, Hirofumi Kai, Laura Perin, Moumita Barua, Roser Torra, Jeff H. Miner, Laura Massella, Danica Galesic Ljubanovic, Rachel Lennon, Andre B. Weinstock, Bertrand Knebelmann, Agne Cerkauskaite, Susie Gear, Oliver Gross, A. Neil Turner, Margherita Baldassarri, Anna Maria Pinto, Alessandra Renieri

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Endocrinology & Metabolism

Correlation of PET-MRI, Pathology, LOH, and Surgical Success in a Case of CHI With Atypical Large Pancreatic Focus

Hendrik Vossschulte, Konrad Mohnike, Klaus Mohnike, Katharina Warncke, Ayse Akcay, Martin Zenker, Ilse Wieland, Ina Schanze, Julia Hoefele, Christine Foerster, Winfried Barthlen, Kim Stahlberg, Susann Empting

Summary: This case report discusses a patient with CHI. The study found two activity peaks in the patient's pancreas, and surgical resection of these areas resulted in normalized blood sugar levels. Analysis of tissue samples indicated that a second genetic hit in pancreatic precursor cells was responsible for the atypical pancreatic lesion. The study confirms that the resection of focal lesions can lead to complete cure in CHI patients.

JOURNAL OF THE ENDOCRINE SOCIETY (2022)

Article Biochemistry & Molecular Biology

Pontocerebellar hypoplasia due to bi-allelic variants in MINPP1

Bart Appelhof, Matias Wagner, Julia Hoefele, Anja Heinze, Timo Roser, Margarete Koch-Hogrebe, Stefan D. Roosendaal, Mohammadreza Dehghani, Mohammad Yahya Vahidi Mehrjardi, Erin Torti, Henry Houlden, Reza Maroofian, Farrah Rajabi, Heinrich Sticht, Frank Baas, Dagmar Wieczorek, Rami Abou Jamra

Summary: This study describes eight children with Pontocerebellar hypoplasia (PCH) from four unrelated families carrying homozygous variants in the MINPP1 gene. These variants result in either a complete absence of MINPP1, impaired protein folding, destabilization of protein structure or reduction in protein stability, leading to the pathogenesis of the disease. This study presents MINPP1 as a novel autosomal recessive gene associated with PCH.

EUROPEAN JOURNAL OF HUMAN GENETICS (2021)